학술논문

Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without Comorbidities.
Document Type
Article
Source
NPJ Vaccines; 11/9/2022, Vol. 7 Issue 1, p1-13, 13p
Subject
COVID-19 vaccines
IMMUNE response
SARS-CoV-2 Omicron variant
SARS-CoV-2 Delta variant
ADULTS
Language
ISSN
20590105
Abstract
Copyright of NPJ Vaccines is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)